Nova Leap Health Corp.
NLH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 230.70% | 56.79% | 113.95% | 61.68% | -26.21% |
| Total Depreciation and Amortization | -34.04% | -37.68% | -40.15% | -36.35% | -34.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -136.71% | -11.82% | -56.61% | 119.96% | 263.96% |
| Change in Net Operating Assets | 141.48% | 3,840.54% | 88.82% | 104.75% | 190.85% |
| Cash from Operations | -35.58% | 14.08% | -14.65% | 136.04% | 111.07% |
| Capital Expenditure | 10.71% | 100.00% | 100.00% | 100.00% | 60.67% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -100.00% | -67.33% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6,787.45% | -686.16% | -502.41% | 100.00% | 58.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 76.97% | 52.83% | 58.46% | 37.10% | 16.02% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 80.26% | 95.06% | 91.50% | 88.31% | 81.10% |
| Cash from Financing | 129.01% | 55.72% | 20.40% | -24.53% | -77.99% |
| Foreign Exchange rate Adjustments | -380.60% | -84.25% | 95.24% | 105.67% | 157.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 234.43% | 123.09% | -36.92% | 129.55% | 17.99% |